World
The company has had talks with at least one firm in recent months as it considers going private.
Octopus Energy's valuation rises to $9b after CPPIB, Generation Investment raise stake
PE firms weigh potential buyout of NY-based fitness company Peloton
CICC, Citic, JPMorgan slash investment banking jobs in China as deals stall
Former Dallas Fed chief Kaplan named Goldman Sachs vice chairman
India Digest: Parseable, Superplum, Cornext raise funding
More Stories
CVC-led group to buy 65% stake in Lippo-backed hospital chain Siloam for around $1.6b
Jungle Ventures looking to dig into SE Asia’s F&B sector with Yay! Group investment
Sale process of Malaysia’s Island Hospital by PE firm Affinity draws investors
Singapore co-working laboratory provider NSG BioLabs raises $14.5m
Troubled crypto platform Zipmex appoints liquidator to wind up operations
India
Launched late last year, the fund garnered capital commitments of over $39m in the first close.
Indonesia
CVC Capital, an existing shareholder, holds a 26.18% stake in the chain through Prime Health Company Limited.
Singapore
PE firm Celadon Partners and ClavystBio, a life sciences investor set up by Temasek, invested.
PE investments in India touched a six-year low at $24b in the financial year ended March 2024.
NephroPlus operates dialysis centres mainly in India, the Philippines and Uzbekistan.
Philippines
The consortium also includes DEG, BIO, and OP Finnfund Global Impact Fund I.
Perficient has operations spanning the United States, Latin America, Europe and India.
Malaysia
The deal marks Ekuinas’s third investment in the pharmaceutical sector.
Morgan Stanley Private Equity Asia and India Life Sciences have jointly acquired a controlling stake.